Baillie Gifford - Q1 2020 holdings

$92.3 Billion is the total value of Baillie Gifford's 705 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 9.5% .

 Value Shares↓ Weighting
GOOG BuyAlphabet Inc Class Ccap stk cl c$2,946,643,000
-12.4%
2,534,070
+0.7%
3.19%
-1.8%
MELI BuyMercadoLibre$2,274,303,000
-9.7%
4,654,923
+5.7%
2.46%
+1.3%
DXCM BuyDexcom Inc$1,300,723,000
+23.5%
4,830,552
+0.3%
1.41%
+38.4%
ZM BuyZoom Video Communications Inccl a$1,047,612,000
+525.0%
7,169,538
+191.0%
1.14%
+600.6%
PDD BuyPinduoduo Inc ADRsponsored ads$982,007,000
+53.2%
27,255,238
+60.8%
1.06%
+71.6%
WDAY BuyWorkday Inccl a$918,814,000
+7.4%
7,055,860
+35.6%
1.00%
+20.3%
ALNY BuyAlnylam Pharmaceuticals$915,621,000
-2.9%
8,411,769
+2.7%
0.99%
+8.9%
TDOC BuyTeladoc$895,028,000
+86.5%
5,774,002
+0.7%
0.97%
+109.1%
AJG BuyAJ Gallagher & Co$586,521,000
-9.0%
7,195,689
+6.3%
0.64%
+1.9%
BIDU BuyBaidu.com Sponsored ADRspon adr rep a$525,489,000
-19.9%
5,213,705
+0.4%
0.57%
-10.3%
MLM BuyMartin Marietta Materials$518,324,000
-32.0%
2,739,119
+0.5%
0.56%
-23.7%
SGEN BuySeattle Genetics$493,919,000
+1.6%
4,280,810
+0.6%
0.54%
+13.8%
PTON BuyPeloton Interactive Inc$463,708,000
+18.8%
17,465,459
+27.1%
0.50%
+33.2%
TER BuyTeradyne$443,375,000
-20.6%
8,184,879
+0.0%
0.48%
-10.9%
Z BuyZillow Group Inc Class Ccl c cap stk$407,653,000
-21.5%
11,317,386
+0.1%
0.44%
-12.0%
RYAAY BuyRyanair ADRsponsored adr ne$399,771,000
-32.9%
7,530,081
+10.8%
0.43%
-24.7%
ABMD BuyAbiomed$395,761,000
-14.7%
2,726,380
+0.2%
0.43%
-4.2%
SE BuySEA Ltd ADRadr$372,690,000
+353.4%
8,410,972
+311.6%
0.40%
+411.4%
NIO BuyNIO Inc ADRspon ads$282,849,000
-30.6%
101,744,131
+0.4%
0.31%
-22.3%
BAP BuyCredicorp$273,852,000
-31.6%
1,914,104
+1.9%
0.30%
-23.3%
JD BuyJD.Com Inc - ADRspon adr cl a$259,051,000
+47.0%
6,396,323
+27.9%
0.28%
+65.3%
WSO BuyWatsco Inc$253,506,000
-12.2%
1,604,162
+0.1%
0.28%
-1.4%
VALE BuyVale SA ADRadr$253,148,000
-35.4%
30,536,600
+2.9%
0.27%
-27.7%
WUBA Buy58.Com Inc Adrspon adr rep a$216,851,000
-24.6%
4,450,959
+0.1%
0.24%
-15.5%
TME BuyTencent Music Entertainment ADRsponsored ads$203,825,000
+7.4%
20,260,972
+25.4%
0.22%
+20.8%
ITUB BuyItau Unibanco Holding SA-ADRspon adr rep pfd$189,405,000
-50.6%
42,184,011
+0.6%
0.20%
-44.7%
GOOGL BuyAlphabet Inc Class Acap stk cl a$178,706,000
-6.4%
153,798
+7.9%
0.19%
+5.4%
PBR BuyPetrobras Common ADRsponsored adr$178,209,000
-59.4%
32,401,631
+17.7%
0.19%
-54.5%
HHC BuyHoward Hughes$169,576,000
-16.9%
3,356,603
+108.6%
0.18%
-6.6%
ZLAB BuyZai Lab ADRadr$160,349,000
+26.8%
3,114,800
+2.5%
0.17%
+42.6%
DNLI BuyDenali Therapeutics$159,861,000
+20.9%
9,129,752
+20.3%
0.17%
+35.2%
CPA BuyCopa Holdings S Acl a$142,878,000
-58.0%
3,154,744
+0.2%
0.16%
-52.9%
MYGN BuyMyriad Genetics Inc$128,360,000
-47.4%
8,970,006
+0.1%
0.14%
-41.1%
BBD BuyBanco Bradesco Pn ADRsp adr pfd new$119,244,000
-54.0%
29,370,158
+1.5%
0.13%
-48.4%
GKOS BuyGlaukos Corp$112,447,000
-42.3%
3,643,752
+1.9%
0.12%
-35.1%
YEXT BuyYext Inc$108,870,000
-28.7%
10,683,923
+0.9%
0.12%
-20.3%
MRNA BuyModerna Inc$106,619,000
+59.6%
3,559,884
+4.2%
0.12%
+78.5%
LYFT BuyLyft Inc Class A Common$100,067,000
-36.9%
3,726,896
+1.1%
0.11%
-29.4%
STAA BuyStaar Surgical$63,504,000
-7.1%
1,968,516
+1.3%
0.07%
+4.5%
GRFS NewGrifols ADRsp adr rep b nvt$63,958,0003,175,697
+100.0%
0.07%
AVAV BuyAerovironment$50,373,000
-0.2%
826,330
+1.1%
0.06%
+12.2%
PCRX BuyPacira BioSciences$47,341,000
-24.7%
1,411,892
+1.8%
0.05%
-16.4%
CDXS BuyCodexis$45,615,000
-24.7%
4,087,317
+7.9%
0.05%
-16.9%
SPLK BuySplunk Inc$45,224,000
-14.6%
358,263
+1.4%
0.05%
-3.9%
MMYT BuyMakeMyTrip$43,006,000
-43.2%
3,597,299
+8.8%
0.05%
-35.6%
EXAS BuyExact Sciences$42,323,000
-36.5%
729,707
+1.3%
0.05%
-28.1%
BZUN BuyBaozun Spn Adr 1:1sponsored adr$39,120,000
-14.7%
1,400,159
+1.2%
0.04%
-4.5%
BL BuyBlackline$36,490,000
+3.1%
693,592
+1.1%
0.04%
+17.6%
BGNE BuyBeigene Ltdsponsored adr$37,182,000
-22.3%
302,023
+4.6%
0.04%
-13.0%
TRUP BuyTrupanion$36,151,000
-29.9%
1,388,782
+0.8%
0.04%
-22.0%
IRBT BuyiRobot$33,671,000
-18.5%
823,274
+0.9%
0.04%
-10.0%
IPGP BuyIPG Photonics Corp$32,391,000
-23.0%
293,708
+1.2%
0.04%
-14.6%
UPS BuyUnited Parcel Servicecl b$32,389,000
-19.4%
346,702
+1.0%
0.04%
-10.3%
CYBR NewCyberArk Software Ltd$30,156,000352,448
+100.0%
0.03%
NATI BuyNational Instruments Corp$29,717,000
-21.1%
898,340
+1.0%
0.03%
-11.1%
WORK BuySlack Technologies Inc$28,169,000
+168.4%
1,049,526
+124.8%
0.03%
+210.0%
RAMP BuyLiveramp Holdings Inc$26,751,000
-30.7%
812,600
+1.2%
0.03%
-21.6%
PBRA BuyPetrobras Pref ADRsp adr non vtg$26,658,000
-62.3%
4,945,837
+4.3%
0.03%
-57.4%
JMIA BuyJumia Technologies Ag ADRsponsored ads$27,001,000
-56.6%
9,246,855
+0.1%
0.03%
-51.7%
EB BuyEventbrite Inc Class A$23,195,000
-63.1%
3,177,353
+1.9%
0.02%
-59.0%
AMBA BuyAmbarella$20,289,000
-18.9%
417,810
+1.2%
0.02%
-8.3%
XYL BuyXylem$20,553,000
+11.5%
315,560
+34.9%
0.02%
+22.2%
RUBY BuyRubius Therapeutics Inc$18,943,000
-53.1%
4,256,900
+0.1%
0.02%
-46.2%
FTCH BuyFarfetch$18,198,000
-14.1%
2,303,432
+12.5%
0.02%0.0%
FARO BuyFaro Technologies$18,861,000
-10.8%
423,843
+0.9%
0.02%0.0%
EVER BuyEverQuote Inc$16,656,000
-22.7%
634,505
+1.2%
0.02%
-14.3%
ECL BuyEcolab$13,398,000
+9.6%
85,975
+35.7%
0.02%
+25.0%
DE NewDeere & Co$13,747,00099,496
+100.0%
0.02%
SSYS BuyStratasys$13,756,000
-20.5%
862,489
+0.9%
0.02%
-11.8%
INFY BuyInfosys Ltd ADRsponsored adr$13,816,000
-16.4%
1,682,780
+5.1%
0.02%
-6.2%
ADAP BuyAdaptimmune Therapeutics ADRsponds adr$11,843,000
+130.2%
4,354,023
+1.6%
0.01%
+160.0%
ADRO BuyAduro Biotechnology$11,725,000
+134.7%
4,279,324
+1.1%
0.01%
+160.0%
VECO BuyVeeco Instruments$12,057,000
-33.6%
1,259,935
+1.9%
0.01%
-27.8%
CEVA BuyCEVA Inc$11,095,000
-6.7%
445,043
+0.9%
0.01%
+9.1%
AXGN BuyAxogen Inc$10,843,000
-41.3%
1,042,530
+1.0%
0.01%
-33.3%
TROW NewT. Rowe Price$10,749,000110,072
+100.0%
0.01%
ZUO BuyZuora Inc Class A$9,755,000
-43.3%
1,211,688
+1.0%
0.01%
-35.3%
UPWK BuyUpwork Inc$8,834,000
-38.3%
1,369,700
+2.0%
0.01%
-28.6%
DMRC BuyDigimarc$9,547,000
-60.6%
731,574
+1.3%
0.01%
-56.5%
BNFT BuyBenefitfocus Inc$8,152,000
-58.8%
915,048
+1.4%
0.01%
-52.6%
HUYA NewHUYA ADR$7,810,000460,755
+100.0%
0.01%
HCM BuyHutchison China Meditechsponsored adr$3,920,000
-28.2%
219,605
+0.8%
0.00%
-20.0%
KEP BuyKorea Electric Power ADRsponsored adr$1,032,000
-10.3%
136,800
+40.6%
0.00%0.0%
SAGE BuySage Therapeutics Inc$25,000
-28.6%
879
+79.4%
0.00%
WPM BuyWheaton Precious Metals$195,000
+23.4%
7,073
+33.2%
0.00%
HCAT BuyHealth Catalyst Inc$88,000
+2.3%
3,352
+34.5%
0.00%
MBT BuyMobile Telesystems ADRsponsored adr$195,000
-8.9%
25,700
+21.8%
0.00%
MNLO NewMenlo Therapeutics Inc$349,000129,971
+100.0%
0.00%
BBIO NewBridgeBio Pharma Inc$78,0002,700
+100.0%
0.00%
TXG New10X Genomics Inc Class A$99,0001,589
+100.0%
0.00%
ARI BuyApollo Commercial Real Estate Finance REIT$110,000
-50.2%
14,800
+22.3%
0.00%
NLY BuyAnnaly Capital Man.$110,000
-34.1%
21,682
+22.1%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-08
Signatures

The EDGAR filing(s) were signed by:

About Baillie Gifford

Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.

Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.

One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.

Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Amazon.Com42Q3 202310.0%
Tesla Motors42Q3 202310.7%
Illumina42Q3 20236.6%
Baidu.com Sponsored ADR42Q3 202311.6%
Meta Platforms Inc42Q3 20235.0%
MercadoLibre42Q3 20237.3%
Intuitive Surgical42Q3 20233.5%
Moody's Corp42Q3 20231.4%
MasterCard Inc-Class A42Q3 20231.9%
Workday Inc42Q3 20231.4%

View Baillie Gifford's complete holdings history.

Latest significant ownerships (13-D/G)
Baillie Gifford Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oddity Tech LtdSeptember 07, 20234,914,66110.9%
Roblox CorpSeptember 07, 202328,106,2155.0%
SiteOne Landscape Supply, Inc.August 03, 20232,234,9855.0%
UPWORK, INCAugust 03, 20236,565,2304.9%
CHINOOK THERAPEUTICS, INC.August 01, 2023844,6842.0%
MELI Kaszek Pioneer CorpSold outJuly 05, 202300.0%
Abcam plcJune 08, 202311,331,7264.9%
CARVANA CO.June 06, 202361,9890.1%
EverQuote, Inc.May 03, 20231,358,4395.0%
CEMEX SAB DE CVMarch 03, 2023752,914,1105.0%

View Baillie Gifford's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-04
SC 13G/A2024-04-04
SC 13G/A2024-03-07
SC 13G/A2024-03-06
SC 13G/A2024-02-07
SC 13G/A2024-02-01
SC 13G/A2024-02-01
SC 13G/A2024-01-30
SC 13G/A2024-01-30
SC 13G/A2024-01-30

View Baillie Gifford's complete filings history.

Compare quarters

Export Baillie Gifford's holdings